Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huafu Li

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Cell and Developmental Biology|September 15, 2025
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Aging|February 3, 2021
High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancerHuafu Li, Chunming Wang, Linxiang Lan, et al.
Nature|July 3, 2024
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistanceHengxing Chen, Yun Li, Huafu Li, et al.
Cellular and Molecular Life Sciences : CMLS|February 18, 2022
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stabilityHuafu Li, Chunming Wang, Linxiang Lan, et al.
Nature|September 24, 2025
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancerHuafu Li, Linxiang Lan, Hengxing Chen, et al.
Nature|June 29, 2022
GREM1 is required to maintain cellular heterogeneity in pancreatic cancerLinxiang Lan, Theodore Evan, Huafu Li, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Cell and Developmental Biology|September 15, 2025
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Aging|February 3, 2021
High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancerHuafu Li, Chunming Wang, Linxiang Lan, et al.
Nature|July 3, 2024
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistanceHengxing Chen, Yun Li, Huafu Li, et al.
Cellular and Molecular Life Sciences : CMLS|February 18, 2022
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stabilityHuafu Li, Chunming Wang, Linxiang Lan, et al.
Nature|September 24, 2025
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancerHuafu Li, Linxiang Lan, Hengxing Chen, et al.
Nature|June 29, 2022
GREM1 is required to maintain cellular heterogeneity in pancreatic cancerLinxiang Lan, Theodore Evan, Huafu Li, et al.
Pageof 3